Information for patients taking Reyataz

(atazanavir)
 

These pages contain some basic information for people taking Reyataz as part of their anti-HIV combination therapy.


Please take note: this information can't replace the advice of your doctor, or that in the Reyataz patient information leaflet (the leaflet inside the Reyataz packaging). Please read that leaflet before you start your medication – download it here.


Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.gov.uk. Adverse events should also be reported to Bristol-Myers Squibb using the Contact Us link on this website.